Ditchcarbon
  • Contact
  1. Organizations
  2. Sinco Pharma
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
CN
updated a day ago

Sinco Pharma

Company website

Sinco Pharma, a leading player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a key provider of high-quality pharmaceutical products, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. With a commitment to innovation and quality, Sinco Pharma offers a diverse range of products, including generic medications and custom synthesis services, which are distinguished by their rigorous quality control and compliance with international standards. The company has achieved significant milestones, including certifications from major regulatory bodies, solidifying its market position as a trusted supplier in the global pharmaceutical landscape. Sinco Pharma continues to expand its reach, driven by a dedication to enhancing healthcare outcomes worldwide.

DitchCarbon Score

How does Sinco Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Sinco Pharma's score of 26 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

Sinco Pharma's reported carbon emissions

In 2022, Sinco Pharma reported total carbon emissions of approximately 299,710 kg CO2e, comprising Scope 1 emissions of about 93,260 kg CO2e from mobile combustion, Scope 2 emissions of around 171,420 kg CO2e from purchased electricity, and Scope 3 emissions of about 64,170 kg CO2e from business travel, along with 2,860 kg CO2e from waste generated in operations. As a current subsidiary of Sinco Pharmaceuticals Holdings Limited, Sinco Pharma's emissions data is cascaded from its parent company. However, there are currently no specific reduction targets or climate pledges disclosed by Sinco Pharma. The company has not outlined any initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks, indicating a potential area for future commitment and improvement in their climate strategy. Overall, while Sinco Pharma has provided a comprehensive overview of its emissions, the absence of reduction targets suggests an opportunity for the company to enhance its climate commitments in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
93,260
Scope 2
171,420
Scope 3
67,030

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sinco Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sinco Pharma is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sinco Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Losan Pharma GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Medochemie Limited

CY
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Bruschettini Srl

IT
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

GlaxoSmithKline Manufacturing S.p.A.

IT
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 4 hours ago

CSL Behring (Australia) Pty Ltd

AU
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy